WEX Pharmaceuticals Inc. is a late-stage drug development company in Vancouver, Canada dedicated to the development, manufacture, and commercialization of Halneuron®, a new novel non-opioid analgesic. Halneuron® is a highly selective sodium channel blocker and represents a breakthrough in painkiller technology: - Non-addictive, no withdrawal symptoms and no euphoria - No build of up of tolerance over time - A long duration of pain relief with minimal side effects - Safe for human use and tested in over 700 people to date Halneuron® is entering into Phase III clinical trials for chemotherapy-induced neuropathic pain and concurrently being tested in other pain indications.